Introduction
Peroxisome proliferators (PP*) are mitogens and carcinogens in rodent liver (1) . PP induce large pre-neoplastic lesions (homogenous basophilic foci) that contain rapidly proliferating hepatocytes. Increased lesion size and enhanced DNA synthesis *Abbreviations: PP, peroxisome proliferator; HGF, hepatocyte growth factor; PPAR, peroxisome proliferator-activated receptor; PPRE, peroxisome proliferator response elements.
© Oxford University Press observed in these basophilic foci compared with other focal phenotypes and surrounding hepatocytes are associated with tumor development (2, 3) . In addition, proliferative lesions induced by PP regress following cessation of exposure, indicating that development of the lesion is dependent upon continuous PP alteration of growth regulatory pathways (4) .
The c-met oncogene encodes for a growth-related protein that is involved in mitogenesis (5, 6) . The c-met gene product is the receptor for hepatocyte growth factor (HGF), a potent hepatocyte mitogen whose levels increase in serum immediately following partial hepatectomy (7) . The c-metfHGF mitogen growth loop may be involved in liver cancer formation, since increased expression of c-met is observed in human hepatocellular carcinomas and other neoplasms (8) (9) (10) .
The c-myc gene product is a growth-associated transcription factor. The amounts of the transcript rapidly and transiently increase in liver following partial hepatectomy in rats (11). The protein encoded by the c-myc gene may be involved in carcinogenesis (12). In addition, slight but prolonged increases in c-myc message are detectable in rat liver following shortterm exposure to WY-14,643 (a potent PP, hepatic mitogen and carcinogen in rodents), in contrast to partial hepatectomy (11). The oncogene c-myc is also increased at the mRNA level in rat liver tumors induced by BR-931, a PP and rodent hepatocarcinogen (13) .
The peroxisome proliferator-activated receptor (PPAR) is altered upon exposure to PP in various reporter systems (14) (15) (16) . Thorough evaluation of PPAR gene expression in PPtreated rats has not been reported, nor has the involvement of PPAR in cell replication been studied. Rapidly growing preneoplastic lesions induced by PP expressed decreased levels of fatty acid metabolizing peroxisomal enzymes relative to surrounding parenchyma (17) . Peroxisome proliferator response elements (PPRE) have been shown for genes encoding enzymes in the peroxisomal p-oxidation pathway, but as yet PPRE have not been found on growth-associated genes (18) . PPAR may be negatively correlated with growth of PP-induced lesions. To determine genes responsible for enhanced growth in PP-induced lesions we sought to assess expression of c-met, c-myc and PPAR-a in tumors induced by WY-14,643 (a potent PP) and in non-lesion liver from chronically exposed rats. Determination of genes involved in PP-induced hepatocarcinogenesis should lead to better risk estimation for humans exposed to these chemicals. 
Materials and methods

Chemicals
Animals and dosing
Thirteen 9-week-old male F-344 rats were obtained from Charles River Breeding Laboratories Inc. (Raleigh, NC). Care and use of these animals was in accordance with the recommendations listed in the Guide for Care and Use of Laboratory Animals (DHEW Publication no. NIH 86-033). Rats were housed two to a cage and exposed to a 12 h light/dark cycle with room temperature and humidity maintained at 22 ± 2°C and 50 ± 5% respectively. Deionized, filtered water and the standard base diet (NIH-07) were available ad libitum.
WY-14,643 was blended into the NIH-07 chow to a concentration of 1000 p.p.m. Beginning at 13 weeks of age rats were fed chow containing WY-14,643 ad libitum for 22 or 78 weeks. Two rats per group per time point were used in the first experiment. In the second experiment the control group contained four rats and the WY 14,643-exposed group contained five rats. All animals received [ 3 H]thymidine via an osmotic pump (Alza Co., Palo Alto, CA) implanted in the subcutis 6 days prior to necropsy. Each pump contained 2 ml [ 3 H]thymidine (1 mCi/ml) delivered at a flow rate of 10 (il/h.
Necropsy
At necropsy samples of liver (22 and 78 weeks of exposure) and liver tumor (78 weeks of exposure) were frozen in liquid nitrogen and stored at -70°C or fixed in 10% neutral buffered formalin. Liver tumor samples were dissected away from non-lesion liver prior to freezing. Formalin-fixed liver samples were embedded in paraffin, sectioned and stained with hematoxylin and eosin. Autoradiographic slides were dipped in emulsion (Kodak NTB-2) and exposed in darkness at -20°C for 11 weeks. A section of duodenum was included with the liver as a positive control for nuclear labeling and to confirm continuous delivery of [ 3 H]thymidine. Following development sections were counterstained with hematoxylin and eosin. Liver sections were examined using light microscopy and tumors were diagnosed as adenomas or carcinomas according to standard criteria. Total RNA was extracted from frozen liver samples using the chloroform/phenol extraction technique with the RNAzol kit (TEL-TEST 'B' Inc., Friendswood, TX), according to the manufacturer's instructions provided with the kit.
mRNA analysis mRNA was purified from total RNA using oligodeoxythymidylate cellulose columns according to standard techniques (19) . Aliquots of mRNA (5 u.g) were heat denatured and loaded onto formaldehyde-agarose gels and electrophoresis was performed overnight (20) . RNA was transferred from the gels to nitrocellulose membranes by capillary blotting and bound to the membrane by exposure to UV light in a Stratalinker (Strategene, La Jolla, CA) (20) .
The following probes were used: mouse PPAR-a (21), c-met (a gift of M.Ostersen, NCI-Frederick Cancer Research Facility, Frederick, MD), c-myc (Oncor, Gaithersburg, MD) and albumin (a gift of Dr Larry Kier, Monsanto Corp., St Louis, MO). Probes were labeled to a specific activity of ~10 8 c.p.m. by nick translation or random oligonucleotide priming according to the manufacturer's recommendations (Amersham, Arlington Heights, IL) using standard protocols (20) . Hybridization was carried out in 40% formamide, 3X SSC at 42°C. Membranes were exposed to X-ray film with intensifying screens for from 1.5 h to 4 days. Densitometry was carried out on autoradiograms using an LBK Ultroscan XL Enhanced Laser Densitometer (Pharmacia LKB Biotechnology, Uppsala, Sweden). Albumin expression was used to normalize expression of other transcripts, since its expression is relatively unaltered by changes in cell replication in the liver (22) and hepatocyte replication is significantly increased in rat liver following chronic WY 14,643 exposure, especially in lesions (2, 3, 23) . Transcript sizes determined for each target mRNA were consistent with the expected size (~8 kb for c-met, 2.3 kb for c-myc and ~7.5 kb for PPAR-a). Densitometry readings from the larger sample sizes derived from the 78 week exposure groups were compared using the Student-Newman-Keuls multiple comparison test, with the significance level set at P =s 0.05.
Results
Livers from rats exposed to WY-14,643 for 22 or 78 weeks were diffusely enlarged, consistent with hepatomegalic effects reported previously for these compounds (23) . Livers from animals treated with WY-14,643 for 78 weeks also contained multiple, large discrete tumors. Seven tumors from five animals were examined under the light microscope. Of the seven, four were hepatocellular adenomas and three were carcinomas. Hepatocytes within hepatocellular tumors showed evidence of proliferation by increased incorporation of [ Evaluation of liver mRNA levels from rats exposed to WY-14,643 for 22 weeks indicated a lack of a treatment-related effect for c-met expression (Figure 2 ). At the 78 week time point, however, the c-met transcript was increased in tumors compared with untreated rat liver (~9-fold for c-met; Figure  2 ). Slight increases were detected in transcript levels for tumor compared with surrounding non-lesion parenchyma (~2-fold for c-mei) and for non-lesion liver from WY-14,643-exposed animals as compared with liver from age-matched control rats (~5-fold for c-met; Figure 2 ).
Alterations in PPAR-a mRNA levels at the 22 week time point were similar to those observed for c-met in that there was little change in the amount of PPAR-a transcript. Lack of PPAR-a induction was unexpected, given the presence of PPRE on fatty acid metabolizing enzymes that are up-regulated by PP in other systems (24) . Decreased PPAR-a message in liver from 78 week control rats as compared with liver from 22 week control rats suggests an age-dependent decline in PPAR expression.
To more clearly define the magnitude of increased expression of c-met and PPAR-a the group sizes for the 78 week exposure time point were increased. Since there was no altered expression observed at 22 weeks for these gene transcripts, samples from rats treated for 22 weeks were excluded from subsequent experiments. Also, c-myc transcript levels were evaluated using the large group sizes. Significant increases in tumor-derived mRNA were observed for c-met and c-myc transcripts as compared with age-matched control liver ( Figure  3 and Table I ). In addition, surrounding non-lesion liver from WY-14,643-exposed animals contained increased levels of these transcripts as compared with age-matched rat non-lesion liver. This increase was only significant for the c-myc transcript (Table I) . Slight but non-significant increases in c-met and cmyc mRNA levels were detected in tumors as compared with surrounding non-lesion liver from control rats ( Figure 3 and Table I ). PPAR-a mRNA levels were altered in a manner similar to the first experiment in that tumor levels were significantly increased over age-matched control rat liver (~6-fold), but only slightly elevated (<2-fold) when compared with surrounding non-lesion liver ( Figure 3 and Table II ).
Discussion
In this study mRNA levels of genes representing multiple growth regulatory pathways were evaluated to elucidate their possible involvement in PP-induced hepatocarcinogenesis.
Although alterations in the expression of each gene were induced by WY-14,643 compared with control liver, no significant changes in expression were observed between liver tumors and surrounding parenchyma. The slight increases detected in gene expression in tumors were consistent, but not nearly of the magnitude that one would expect for genes that are contributing significantly to the growth of these tumors at the level of transcriptional regulation. This seems especially true in the light of the dramatic differences in the expression of growth-associated genes following partial hepatectomy. For example, c-myc mRNA was elevated 27-fold over nonhepatectomized liver 6 h post-operatively and levels of the epidermal growth factor receptor transcript increased 9-fold in hepatectomized liver (11, 25) . Post-transcriptional alterations of the genes studied herein cannot be ruled out based on the amounts detected at the mRNA level. Some true increases in tumor mRNA expression may have been partially masked by contamination of surrounding liver by grossly undetectable pre-neoplastic lesions that falsely elevated mRNA levels in apparently normal liver tissue. However, this possibility is unlikely, since PP typically produce small numbers of rapidly growing pre-neoplastic lesions compared with other chemicals (2, 26) . Also, if contamination had occurred, then one would expect 78 week non-lesion liver levels to be markedly elevated compared with 22 week nonlesion liver levels. In addition, upon microscopic examination of liver sections from 78 week WY-14,643-treated rats the tumors observed were fairly discrete. Further, if tumor-derived mRNA levels were actually elevated to the extent observed in other instances of rapid growth, a slight dilution effect would probably not fully mask a significant increase in tumor-specific mRNA expression.
The lack of significant changes in c-met expression in PPinduced tumor compared with surrounding non-lesion parenchyma was somewhat surprising, considering reported increases in c-met in many types of tumors, including human liver tumors. For many of these studies c-met expression was compared with normal tissue from different patients, rather than adjacent non-lesion tissue (10). If similar assessments had been made in the experiments reported here, similar significant increases in tumor mRNA levels would have been observed. However, comparison with adjacent non-lesion parenchyma may be more appropriate, since it can be related to the increased cell replication in the tumors.
The small differences in c-myc transcript levels between tumor and surrounding non-lesion are interesting in that c-myc is a well-known cell cycle-associated gene (6, 27) . There are enormous differences in the number of cycling hepatocytes in rapidly growing PP-induced lesions compared with surrounding liver tissue (2) and yet this difference is not reflected in relative c-myc mRNA levels. The observed changes in c-myc in this study are consistent with those reported for tumors induced by BR-931, a PP similar to WY-14,643 (13) . Generalized, chronic dysregulation of c-myc by PP may provide a background upon which further alterations in gene expression are incurred within certain sub-populations of hepatocytes that then become neoplastic.
Substantial evidence exists for linking members of the PPAR family to fatty acid metabolism. However, the involvement of PPAR in cell replication remains to be elucidated. Certainly, the results of experiments reported here do not support a role for PPAR-a in PP-induced hepatocyte replication.
It could be argued that the lack of significant PPARoc transcript increase in tumor compared with surrounding parenchyma would be expected, given the decreased expression of peroxisomal fatty acid metabolizing enzymes observed at the protein level in PP-induced pre-neoplastic altered hepatocellular foci (17) . However, the relationship between PPinduced peroxisomal enzyme induction and cell replication has not been definitively dissociated (17, 28, 29) . The possible involvement of PPAR in hepatocellular growth regulation needs to be explored further.
In conclusion, these results suggest that modulations of c-met, c-myc and PPAR may not be major determinants of the differential growth of PP-induced hepatic tumors in rodents.
